Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.850
0.00 (0.00%)
Nov 24, 2025, 4:00 PM EST
Veradigm Revenue
In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.
Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.43
Revenue / Employee
240.01K
Employees
2,450
Market Cap
841.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 588.02M | 10.59M | 1.83% |
| Dec 31, 2021 | 577.43M | 21.31M | 3.83% |
| Dec 31, 2020 | 556.12M | -1.08B | -65.94% |
| Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
| Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Tian'an Technology Group | 2.12M |
Veradigm News
- 8 days ago - Veradigm Launches Enhanced Ambient Scribe Capabilities - Business Wire
- 15 days ago - Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution - Business Wire
- 22 days ago - Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer - Business Wire
- 7 weeks ago - Veradigm Inc. (MDRX) Investor Update Call (Transcript) - Seeking Alpha
- 7 weeks ago - Veradigm Inc. - Special Call - Seeking Alpha
- 2 months ago - Veradigm Inc (MDRX) Q2 2025 Earnings: Revenue Falls Short at $145-$148 Million, Cash Reserves ... - GuruFocus
- 2 months ago - Veradigm Provides 2025 Business Update - Business Wire
- 2 months ago - DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Veradigm LLC Customers Whose Data May Have Been Compromised - GlobeNewsWire